Literature DB >> 27448706

WNT Signaling in Cutaneous Squamous Cell Carcinoma: A Future Treatment Strategy?

Victoria Sherwood1, Irene M Leigh2.   

Abstract

The molecular mechanisms underlying cutaneous squamous cell carcinoma are less well established than those for other common skin cancers, but recent evidence has highlighted a potentially critical role for WNT signaling in both the development and progression of cutaneous squamous cell carcinoma. WNT pathways are aberrantly regulated in multiple tumor types (albeit in a context-dependent manner), and this has stimulated the development of WNT inhibitory compounds for cancer treatment. In this review, we examine existing evidence for a role of WNT signaling in cutaneous squamous cell carcinoma and discuss if WNT inhibition represents a realistic therapeutic strategy for the future.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27448706     DOI: 10.1016/j.jid.2016.05.108

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  MicroRNA-34a directly targets high-mobility group box 1 and inhibits the cancer cell proliferation, migration and invasion in cutaneous squamous cell carcinoma.

Authors:  Shanshan Li; Chengqun Luo; Jun Zhou; Yong Zhang
Journal:  Exp Ther Med       Date:  2017-10-02       Impact factor: 2.447

2.  Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion.

Authors:  Felicia Cooper; Andrew M Overmiller; Anthony Loder; Donna M Brennan-Crispi; Kathleen P McGuinn; Molly R Marous; Theresa A Freeman; Natalia A Riobo-Del Galdo; Linda D Siracusa; James K Wahl; Mỹ G Mahoney
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

Review 3.  Deciphering UV-induced DNA Damage Responses to Prevent and Treat Skin Cancer.

Authors:  Jihoon W Lee; Kajan Ratnakumar; Kai-Feng Hung; Daiki Rokunohe; Masaoki Kawasumi
Journal:  Photochem Photobiol       Date:  2020-05-04       Impact factor: 3.421

4.  Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis.

Authors:  Yan-Hong Cui; Seungwon Yang; Jiangbo Wei; Christopher R Shea; Wen Zhong; Fang Wang; Palak Shah; Muhammad G Kibriya; Xiaolong Cui; Habibul Ahsan; Chuan He; Yu-Ying He
Journal:  Nat Commun       Date:  2021-04-12       Impact factor: 17.694

Review 5.  A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.

Authors:  Hubert Pakula; Dongxi Xiang; Zhe Li
Journal:  Cancers (Basel)       Date:  2017-01-27       Impact factor: 6.639

Review 6.  MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.

Authors:  Natalia García-Sancha; Roberto Corchado-Cobos; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

7.  Chronic expression of p16INK4a in the epidermis induces Wnt-mediated hyperplasia and promotes tumor initiation.

Authors:  Narmen Azazmeh; Benjamin Assouline; Eitan Winter; Shmuel Ruppo; Yuval Nevo; Alexander Maly; Karen Meir; Agnieszka K Witkiewicz; Jonathan Cohen; Sophia V Rizou; Eli Pikarsky; Chen Luxenburg; Vassilis G Gorgoulis; Ittai Ben-Porath
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

8.  Increased Expression of Flightless I in Cutaneous Squamous Cell Carcinoma Affects Wnt/β-Catenin Signaling Pathway.

Authors:  Gink N Yang; Xanthe L Strudwick; Claudine S Bonder; Zlatko Kopecki; Allison J Cowin
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

9.  Discovering the Role of FZD4 Gene in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Ke Zhang; Qun Lv; Liming Li; Mingjun Jiang; Fang Fang
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

10.  miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma.

Authors:  Shukai Yuan; Peitao Zhang; Liqi Wen; Shikai Jia; Yufan Wu; Zhenlei Zhang; Lizhao Guan; Zhengquan Yu; Li Zhao
Journal:  Oncogene       Date:  2021-08-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.